中手遊(00302.HK)「新仙劍奇俠傳之揮劍問情」首月流水突破2億人民幣
中手遊(00302.HK)公布,與青瓷聯合發行的《仙劍奇俠傳》系列正版授權劇情冒險卡牌RPG手遊《新仙劍奇俠傳之揮劍問情》首發上線一個月,收入已突破2億元人民幣。
公司表示,該遊戲首發上線前全平台預約量突破800萬,預下載開啟當日成為iOS免費榜第一名,目標將該遊戲打造成為一個具有至少10年超長生命週期的持久產品,在未來的版本規劃中,開發團隊將採納更多元化的玩法,致力於提升玩家長線遊玩體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.